Every year 450,000 people in the U. S. get pneumonia. Every year more than 100,000 of them die. Next year, if they receive prompt and proper medical care, there seems to be no reason for more than 36,000 people to succumb to the suffocating disease that up to now has been the nation's third biggest killer. The official news of this medical triumph came from the Food and Drug Administration, which last week licensed the sale of sulfapyridine (M. & B. 693).
Sulfapyridine, one of the 1,000 relatives of sulfanilamide, acts on all 32 types of pneumonia. First used in England last...
To continue reading:
or
Log-In
